Skip to main content
Qurient Co., Ltd. logo

Qurient Co., Ltd. — Investor Relations & Filings

Ticker · 115180 ISIN · KR7115180002 KO Professional, scientific and technical activities
Open in API
Filings indexed 437 across all filing types
Latest filing 2024-11-29 Major Shareholding Noti…
Country KR South Korea
Listing KO 115180

About Qurient Co., Ltd.

http://www.qurient.com/

Qurient Co., Ltd. is a clinical-stage biopharmaceutical company focused on developing innovative therapeutics for unmet medical needs. The company operates on a proprietary 'Network R&D' model, a virtual approach that manages drug development programs from early discovery through clinical phases. Its pipeline includes Adrixetinib for chronic graft-versus-host disease (cGvHD), Telacebec for the treatment of tuberculosis, and a next-generation dual-payload Antibody-Drug Conjugate (ADC) platform for oncology. Qurient advances its portfolio through global clinical trials and strategic collaborations to address critical diseases.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, including acquisitions through market purchases and convertible bonds, and identifies the reporting entity and special related parties. This falls under the 'Major Shareholding Notification' category.
2024-11-29 Korean
증권발행결과(자율공시) (제2회차 CB)
Capital/Financing Update Classification · 100% confidence The document is a formal announcement regarding the 'Result of Securities Issuance' (증권 발행결과) for a convertible bond (CB). It details the issuance amount, payment date, and type of security. This falls under the category of capital and financing updates, specifically related to the issuance of debt instruments that can be converted into equity.
2024-11-22 Korean
주요사항보고서(자본으로인정되는채무증권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean financial authorities regarding the issuance of convertible bonds (debt securities recognized as capital). It details the terms of the issuance, including interest rates, maturity, call options, and the purpose of the funds. This falls under the category of capital and financing updates as it describes a specific corporate financing activity.
2024-11-19 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) filed with the Financial Supervisory Service/Korea Exchange regarding the decision to issue convertible bonds (전환사채권 발행결정). This is a formal regulatory filing detailing the terms of a capital financing activity, specifically the issuance of debt securities convertible into equity. It fits the 'Capital/Financing Update' category.
2024-11-19 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by an individual (Byung Girl Rhee) regarding their appointment as a non-executive director at Qurient. This type of filing is a standard regulatory requirement for reporting insider shareholdings and changes in ownership status, which falls under the 'Director's Dealing' category.
2024-11-14 Korean
분기보고서 (2024.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '주식회사 큐리언트' (Qurient Co., Ltd.) covering the period from January 1, 2024, to September 30, 2024. It contains detailed corporate information, business descriptions, and capital structure data, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2024
2024-11-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.